Quark Pharmaceuticals

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the current operational status of Quark Pharmaceuticals in Israel?

Quark Pharmaceuticals ceased to operate in Israel in May 2022 and is currently listed as inactive.

When was Quark Pharmaceuticals founded and where is its headquarters located?

Quark Pharmaceuticals was founded in 1993 and its headquarters is located in Newark, CA, USA.

What is the primary focus of Quark Pharmaceuticals' drug development?

Quark Pharmaceuticals is a late clinical-stage pharmaceutical company focused on the discovery and development of novel RNAi-based therapeutics for unmet medical needs.

Which products of Quark Pharmaceuticals have received Orphan designation and are in global Phase III clinical studies?

Quark Pharmaceuticals has two products, QPI-1002 and QP-1007, which were granted Orphan designation and are in global Phase III pivotal clinical studies for Delayed Graft Function (DGF) and Non Arteritic Ischemic Optic Neuropathy (NAION) respectively.

What was a significant corporate development for Quark Pharmaceuticals in January 2014?

In January 2014, Quark Pharmaceuticals merged with Japan's SBI.

What was the status of the QPI-1002 clinical trial in July 2018?

In July 2018, Quark Pharmaceuticals announced that the first patient was dosed in a Phase 3 clinical trial of QPI-1002 for the prevention of Acute Kidney Injury following cardiac surgery.

What is the name of Quark Pharmaceuticals' Israeli research and development center?

QBI Enterprises Ltd is Quark Pharmaceuticals' Israeli research and development center.

How many employees does Quark Pharmaceuticals currently have worldwide?

Quark Pharmaceuticals has 9 employees worldwide.

Tags